Sale!

Hepatitis B Virus Genotyping Drug Resistance and Quantitative PCR Test Cost

Original price was: 4,060 د.إ.Current price is: 3,650 د.إ.

-10%

The “Hepatitis B Virus Genotyping Drug Resistance and Quantitative PCR Test” is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to provide comprehensive insights into the Hepatitis B Virus (HBV) infection. Priced at 3650 AED, this test serves multiple purposes. Firstly, it identifies the genotype of the HBV, which is crucial for tailoring the most effective treatment plan, as different genotypes can respond differently to medications. Secondly, it assesses the virus for any mutations that might confer resistance to antiviral drugs, ensuring that the chosen treatment regimen remains effective. Lastly, through quantitative PCR (Polymerase Chain Reaction), the test measures the viral load in the blood, offering vital information on the severity of the infection and guiding treatment decisions. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test is a key resource for healthcare providers managing patients with HBV, enabling personalized and precise treatment strategies.

Description

HEPATITIS B VIRUS GENOTYPING DRUG RESISTANCE and QUANTITATIVE PCR Test

Test Name: HEPATITIS B VIRUS GENOTYPING DRUG RESISTANCE and QUANTITATIVE PCR Test

Components: 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes

Price: 3650.0 AED

Sample Condition: Separate plasma asceptically within 2 hours of collection. Ship refrigerated or frozen. 12 hours fasting is recommended

Report Delivery: Sample Daily by 11 am; Report 7 days

Method: Sequencing, Real Time PCR

Test Type: Disorders of Liver

Doctor: Gastroenterologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: 12 hours fasting is recommended

Test Details:

Hepatitis B virus genotyping is a process used to determine the genetic variation of the virus. It involves analyzing the viral genome to identify specific variations or genotypes of the virus. This information can be useful in understanding the epidemiology of the virus and in guiding treatment decisions.

Drug resistance testing is performed to determine if the hepatitis B virus has developed resistance to antiviral drugs. This is important in guiding treatment decisions, as it helps to select the most effective antiviral therapy for the patient. Drug resistance testing involves analyzing specific regions of the viral genome that are known to be associated with drug resistance.

Quantitative PCR (Polymerase Chain Reaction) is a laboratory technique used to measure the amount of viral DNA or RNA in a sample. In the case of hepatitis B, quantitative PCR can be used to measure the viral load, which is the amount of hepatitis B virus present in the blood. This information is important in monitoring the progression of the infection and assessing the response to antiviral therapy.

Overall, hepatitis B virus genotyping, drug resistance testing, and quantitative PCR are important tools in the management of hepatitis B infection. They help in understanding the genetic variation of the virus, selecting appropriate antiviral therapy, and monitoring the effectiveness of treatment.

Test Name	HEPATITIS B VIRUS GENOTYPING DRUG RESISTANCE and QUANTITATIVE PCR Test
Components
Price	3650.0 AED
Sample Condition	3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma asceptically within 2 hours of collection. Ship refrigerated or frozen. 12 hours fasting is recommended
Report Delivery	Sample Daily by 11 am; Report 7 days
Method	Sequencing, Real Time PCR
Test type	Disorders of Liver
Doctor	Gastroenterologist
Test Department:	MOLECULAR DIAGNOSTICS
Pre Test Information	12 hours fasting is recommended.
Test Details	Hepatitis B virus genotyping is a process used to determine the genetic variation of the virus. It involves analyzing the viral genome to identify specific variations or genotypes of the virus. This information can be useful in understanding the epidemiology of the virus and in guiding treatment decisions. Drug resistance testing is performed to determine if the hepatitis B virus has developed resistance to antiviral drugs. This is important in guiding treatment decisions, as it helps to select the most effective antiviral therapy for the patient. Drug resistance testing involves analyzing specific regions of the viral genome that are known to be associated with drug resistance. Quantitative PCR (Polymerase Chain Reaction) is a laboratory technique used to measure the amount of viral DNA or RNA in a sample. In the case of hepatitis B, quantitative PCR can be used to measure the viral load, which is the amount of hepatitis B virus present in the blood. This information is important in monitoring the progression of the infection and assessing the response to antiviral therapy. Overall, hepatitis B virus genotyping, drug resistance testing, and quantitative PCR are important tools in the management of hepatitis B infection. They help in understanding the genetic variation of the virus, selecting appropriate antiviral therapy, and monitoring the effectiveness of treatment.